CSIMarket
 
Immucell Corp  (ICCC)
Other Ticker:  
 
 


Loss on Weak Sales the company amid the fiscal second quarter of 2022

Immucell Corp announced second quarter of 2022 operating deficit of $-0.619007 millions

Published 2022-08-13T18:16:57-04:00
Goran Soko / CSIMarket.com Contributer

For the second quarter of 2022 earnings season Immucell Corp slipped into deficit of $-0.09 per share compare to $0.02 a year prior and Income per Share fell from $0.09 per share from the preceding reporting season.

Revenues receded respectably by -14.982 % to $3.86 millions from $4.54 millions in the comparable reporting season a year prior and sequentially Revenue Tumbled by -35.64 % from $6.00 millions.




For the second quarter of 2022 earnings season Immucell Corp logged net deficit of $-0.684 million, instead of break-even in the comparable reporting season a year before.


Immucell Corp is expected to report next financial recent numbers on November 14, 2022.


    Recently Reported Results
Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Trinity Place Holdings Inc.

Breathtaking numbers, by TPHS during the fiscal time-frame closing Jun 30 2022

For the April to June 30 2022 time-frame TPHS decreased loss per share of $-0.01 per share compare to $-0.20 a year before and EPS improved from $-0.07 per share from the previous reporting period.

Revenues surged sharply by 1743.188 % to $6.36 millions from $0.35 millions in the corresponding reporting period a year before and sequentially Revenues fell by -15.819 % from $7.55 millions.


factory-2937337_960_720 Durable Goods Orders

New orders accelerate in July 2022

New orders increased on the faster pace again, excluding defense booking grew even faster 1.52 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.

Tomography_(CAT)_scan_pd Imaging Diagnostic Systems Inc.

Medical Equipment & Supplies company, deterioration in the corporate performance during the fiscal period ending fourth quarter of 2022

While the earnings season of the April to June 30 2022 period resumes, countless entities have disclosed their earnings. Some of them, are several corporations in the Medical Equipment & Supplies industry. And today, IMDS reported operating shortfall of $-0.157281 millions, for the financial interval ending June 30 2022.


cutting_By_Toby_Hudson_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Lennar Corp

Marvelous Top-line gain by Lennar Corp in the third quarter of 2022

For the financial span ending August 31 2022 Lennar Corp earnings per share grew by 11.28 % of $5.03 per share compare to $4.52 a year ago and earnings per share grew by 12.03 % from $4.49 per share from the preceding quarter.

Revenues increased rapidly by 28.712 % to $8.93 billions from $6.94 billions in the corresponding quarter a year ago and sequentially Revenues grew by 6.888 % from $8.36 billions.


coins-948603__340 Iron Spark I Inc.

Among many corporations, the Iron Spark I Inc. disclosed also the second quarter of 2022 results

After the leaders in the Blank Checks sector, a few lesser known corporations are publishing their numbers. Iron Spark I Inc. mentioned it has realized operating loss of $-0.680845 millions, for the second quarter of 2022.


Factory Orders (Picture Autor: Wolfgang Meinhart) licence GNU Factory Orders

Demand for Manufacturing Goods accelerates in June 2022

orders increased on the faster pace again, as bookings outgrow production.

dollar-1175048_960_720 Gross Domestic Product

Recession became official in the second-quarter of 2022

The second consecutive quarter of GDP contraction, made recession official in the second-quarter of 2022, led by decline in investments and cuts in government outlays.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

The output of the nation's factories, mines and utilities fell in August 2022 by -0.3 %

Fed reported declining U.S. Industrial production in August 2022, as the demand for industrial goods softens.

Messe_2012_by-RaBoe_127_Ra_Boe_Wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Byrna Technologies Inc.

Shortfall higher than a year ago due to Decrease in demand in the financial third quarter of 2022

Lower turnover led to vanishing revenues and larger shortfall, in the financial third quarter of 2022 BYRN Losses have swelled to $-0.07 per share, while Revenue fell by -7.305 % to $12.42 millions, year on year.


pills2_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Schrodinger Inc.

Schrodinger Inc. announced surprisingly bewildering top-line advance, all along the second quarter of 2022

the Biotechnology & Pharmaceuticals company announced in the Jun 30 2022 report surge in Revenues by 29.16 % to $38.47 millions from the corresponding reporting period a year prior, but it has increased a deficit per share at $-0.67 per share.


Justine_Ezarik_By_Brian_Solis__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Knightscope Inc.

Severe hit for the company in the second quarter of 2022

For the April to June 30 2022 time-frame company had turn a round to earnings by exhibiting EPS of $0.02 per share compare to $-4.18 a year before and earnings per share turned positive from $-0.30 per share from the previous quarter.

Revenues fell sharply by -69.416 % to $1.04 millions from $3.41 millions in the comparable quarter a year before and sequentially Revenues advanced by 10.381 % from $0.94 millions.


Justine_Ezarik_By_Brian_Solis__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Technology And Telecommunication Acquisition Corpo

For the financial time-frame ending August 31 2022 company bottom-line turned positive of $0.02 per share compare to $-4.18 a year ago and from $0.00 per share from the previous reporting season.

Revenues remained unaffected to $0.00 millions from $3.41 millions in the corresponding reporting season a year ago and sequentially Revenues advanced from $0.00 millions.


analysis-2811721_960_720 Hubilu Venture Corporation

Hubilu Venture Corporation published Revenue of $0.393802 millions, in thesecond quarter of 2022 financial report

the Consulting Services company proclaimed $0.393802 millions, in Revenue in the financial span ending June 30 2022.


pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Advaxis Inc.

For the May to July 31 2022 period company increased a loss per share of $-3.83 per share compare to $-0.02 a year ago and increased loss from $-1.90 per share from the prior financial reporting period.

Revenues remained unaffected to $0.00 millions from $0.25 millions in the corresponding financial reporting period a year ago and sequentially Revenues advanced from $0.25 millions.




Other ICCC's Earnings Reports

Immucell reported second quarter 2022 earnings

Immucell reported first quarter 2021 earnings

Immucell reported fourth quarter 2021 earnings

       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VNGE's Profile

Stock Price

VNGE's Financials

Business Description

Fundamentals

Charts & Quotes

VNGE's News

Suppliers

VNGE's Competitors

Customers & Markets

Economic Indicators

VNGE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071